Booster vaccine for Venezuelan equine encephalitis in adults
Part of Brain & nervous system, Infections clinical trials.
This study tests a booster dose of an existing vaccine against Venezuelan equine encephalitis (VEE) virus, which can cause brain infection. The goal is to see if the booster safely improves your immune protection against this virus. It is only for people who have received the vaccine before and have low antibody levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have received the VEE vaccine (TC-83) in the past
- You have low levels of protective antibodies against the VEE virus, confirmed by a blood test
- You are at risk of being exposed to the VEE virus (like through work or research)
- You are willing to have follow-up visits and report any side effects
- You agree not to donate blood for 1 year after getting the vaccine
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new vaccine, V4020, that may help protect against Venezuelan equine encephalitis (VEE), a rare but serious virus spread by mosquitoes. It is the first step in humans to see if it is safe and how the body responds.
This study tests how safe a Rift Valley fever (RVF) vaccine is and how strongly it triggers the body’s immune response. You may be eligible if you are at risk of RVF exposure and your blood test shows you don’t already have strong protection.
This early-stage trial tests a new dengue vaccine in healthy adults. Participants will receive the vaccine and later be exposed to a weakened dengue virus to see if the vaccine protects them, while being closely monitored for safety and immune response.
This trial tests a booster dose of an experimental RSV vaccine (SCB-1019T) in healthy adults aged 60-85 who have already received the approved RSV vaccine AREXVY. The goal is to see if the booster is safe and boosts your immune system.
This study tests if a booster dose of one of two Ebola vaccines (Ervebo® or Zabdeno®) is safe and works well in people who already got an Ebola vaccine more than 4 months ago. It's especially for people living in the Democratic Republic of Congo (DRC) who may have been vaccinated before and might need a stronger, longer-lasting immune response.
This study tests a booster vaccine for HIV in people who were part of an earlier HIV vaccine trial. The goal is to see if it's safe and helps the immune system fight HIV better.
Hear when a new Venezuelan Equine Encephalomyelitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.